Align Technology Cash Flow from Operating Activities 2012-2026 | ALGN

Align Technology annual/quarterly cash flow from operating activities history and growth rate from 2012 to 2026. Cash flow from operating activities can be defined as a company's cash flows from operations.
  • Align Technology cash flow from operating activities for the quarter ending March 31, 2026 was $0.370B, a 18.16% decline year-over-year.
  • Align Technology cash flow from operating activities for the twelve months ending March 31, 2026 was $1.342B, a 7.75% decline year-over-year.
  • Align Technology annual cash flow from operating activities for 2024 was $0.738B, a 6.05% decline from 2023.
  • Align Technology annual cash flow from operating activities for 2023 was $0.786B, a 38.16% increase from 2022.
  • Align Technology annual cash flow from operating activities for 2022 was $0.569B, a 51.5% decline from 2021.
Unlock Macrotrends Premium
40 years of data
Faster, ad-free pages
Unlimited data exports
Full-width charts
Align Technology Annual Cash Flow Ops
(Millions of US $)
2024 $738
2023 $786
2022 $569
2021 $1,173
2020 $662
2019 $747
2018 $555
2017 $439
2016 $248
2015 $238
2014 $227
2013 $186
2012 $134
2011 $130
Sector Industry Market Cap Revenue
Medical Medical & Dental Supplies $12.400B $4.035B
Align Technology manufactures and markets a system of clear aligner therapy, intra-oral scanners and CAD/CAM (computer-aided design and computer-aided manufacturing) digital services used in dentistry, orthodontics, and dental records storage. The clear aligner system corrects malocclusion using nearly invisible and removable appliances that gently move the tooth to a desired final position. Align Technology has 2 operating segments, Clear Aligner, known as the Invisalign system and the CAD/CAM Services which is known as the iTero intra-oral scanners and OrthoCAD services.
Stock Name Country Market Cap PE Ratio
McKesson (MCK) United States $106.025B 23.03
Cardinal Health (CAH) United States $50.715B 22.43
Becton Dickinson (BDX) United States $43.913B 11.10
West Pharmaceutical Services (WST) United States $18.493B 35.19
Straumann Holding AG (SAUHY) Switzerland $16.902B 0.00
Cooper (COO) United States $13.894B 16.52
Henry Schein (HSIC) United States $8.645B 15.16
Merit Medical Systems (MMSI) United States $4.072B 19.84
DENTSPLY SIRONA (XRAY) United States $2.339B 7.36
STAAR Surgical (STAA) United States $1.309B 0.00
CONMED (CNMD) United States $1.107B 7.97
Pro-Dex (PDEX) United States $0.165B 19.65
Lifevantage (LFVN) United States $0.053B 5.46
Axe Compute (AGPU) United States $0.022B 0.00